Similarly, correlations of clinical toxicity scores from prostate cancer donors were performed with G2 scores and gene expression of each individual gene PCNA, FXDR, CDKN12 and SESN1 using the non-parametric Spearmans correlation test. This evidence concerns the gene PCNA and prostate carcinoma.